Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-01 · 399 (2) · 2243-2255
DOI: 10.1007/s00210-025-04484-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 18.08.2025. Verfasst von Nasser Ebrahimi Daryani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Ira…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Curcumin, Nanoparticles, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Gastroenterology Fellowship, Department of Internal Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Nanotechnology Research Center Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Ebrahimi Daryani, N., Alebouyeh, M., Tajeddin, E., Nazarbeigi, S., Jaafari, M. R., Elyasi, S., Karbasforooshan, H., Akhondzadeh Basti, S., Abdollahi, A., Aletaha, N., Miri, R., & Moosavian, M. (2026). Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(2), 2243-2255. https://doi.org/10.1007/s00210-025-04484-2
Vancouver
Ebrahimi Daryani N, Alebouyeh M, Tajeddin E, Nazarbeigi S, Jaafari MR, Elyasi S, et al. Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(2):2243-2255. doi:10.1007/s00210-025-04484-2
BibTeX
@article{EbrahimiDaryani2026,
author = {Ebrahimi Daryani, Nasser and Alebouyeh, Masoud and Tajeddin, Elahe and Nazarbeigi, Saeed and Jaafari, Mahmoud Reza and Elyasi, Sepideh and Karbasforooshan, Hedyieh and Akhondzadeh Basti, Shahin and Abdollahi, Alireza and Aletaha, Najmeh and Miri, Rosa and Moosavian, Mehdi},
title = {Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {2},
pages = {2243--2255},
doi = {10.1007/s00210-025-04484-2}
}
EUVIMED